Samuel Hahn

Samuel Hahn, MD, is an Associate Professor of Internal Medicine (Cardiovascular Medicine) at Yale School of Medicine and an Associate Clinical Professor of Medicine. He serves as a Physician Advisor at Yale-New Haven Hospital and holds roles including Medical Director of Safety & Performance Improvement HVC and Co-Chair of the Pharmacy & Therapeutics Anticoagulation & Cardiology Subcommittee at Yale-New Haven Health System. He specializes in interventional cardiology, heart failure, and heart transplant care.

• Education: BS in Bioengineering (University of Pennsylvania, 1989), MD from Harvard Medical School-MIT Health Sciences & Technology (1993). Completed residencies and fellowships in Internal Medicine, Cardiology, and Interventional Cardiology at Massachusetts General Hospital (1993–2000).

Research & Clinical Focus: Dr. Hahn’s work centers on advanced treatments for heart failure and coronary artery disease. He leads clinical efforts integrating technologies like CardioMEMS™ for remote monitoring of pulmonary artery pressure. His expertise spans interventional cardiology, heart failure management, and cardiovascular innovation.

• Awards: Recognized for clinical teaching excellence and clinical cardiology fellowship honors.

Professional Roles: Active in hospital committees including Utilization Review, HVC Informatics, and Pharmacy & Therapeutics. Serves as Associate Director of the Cardiac Catheterization Lab at Yale New Haven Hospital.